Sp-1011-002
Research payments
$841,316
Through program year 2019, $841,316 in research payments was reported against Sp-1011-002, across 461 payments, paid by Adare Pharmaceuticals, Inc..
- Paid by
- Adare Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $841,316 | 461 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Christopher Canale Bountiful, UT Named on 54 payments
- Sridhar Guduri Dublin, OH Named on 32 payments
- Evan Dellon Chapel Hill, NC Named on 31 payments
- Kari Nadeau Stanford, CA Named on 29 payments
- Robert Holbrook Norman, OK Named on 29 payments
- Uday Shankar Hazard, KY Named on 19 payments
- Paul Feuerstadt Hamden, CT Named on 18 payments
- David Bernstein Cincinnati, OH Named on 16 payments
- John Leung Boston, MA Named on 16 payments
- Harry Sarles Rockwall, TX Named on 15 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.